Immunotherapy Results for Mesothelioma

Information on survival rates and results of patients with malignant mesothelioma, pleural mesothelioma, and peritoneal mesothelioma who included immunotherapy in their treatment plans.

Survival Patients Toxicity Treatment Hospital Country Date
29.2 months Malignant Pleural Mesothelioma 3 Chemotherapy Immunotherapy Center Hospitalier Intercommunal de Creteil France 6/2002
26.8 months Pleural mesothelioma 5 Chemotherapy H. Lee Moffitt Cancer Center and Research Institute United States 7/2008
26.0 months Mesothelioma 3 Chemotherapy Immunotherapy Radiation Surgery University of Pisa Italy 12/2006
23.0 months MPM 5 Chemotherapy Surgery University Hospital Zurich Switzerland 4/2007
23.0 months Malignant pleural mesothelioma 3 Biologic therapy Surgery New York University School of Medicine United States 8/2008
18.1 months Malignant Pleural Mesothelioma 5 Radiation < Surgery University of California, San Francisco United States 12/2002
18.0 months Malignant Pleural Mesothelioma 3 Immunotherapy Hopital de la Conception France 11/1998
17.8 months Malignant Pleural Mesothelioma 5 Biologic therapy < Chemotherapy Medical University of Lubeck Germany 3/2003
16.8 months Malignant pleural mesothelioma 4 Chemotherapy Radiation Surgery Memorial Sloan-Kettering Cancer Center United States 6/2009
15.0 months Malignant Pleural Mesothelioma 3 Immunotherapy Ospedale S. Spirito Italy 2/2001
14.8 months Malignant Pleural Mesothelioma 4 Chemotherapy Newcastle General Hospital United Kingdom 8/2002
14.0 months Malignant Pleural Mesothelioma 4 Chemotherapy Ospedale ‘Villa Scassi’ Italy 12/2007
14.0 months Malignant pleural mesothelioma 5 Surgery Memorial Sloan-Kettering Cancer Center United States 3/2008
13.1 months Malignant pleural mesothelioma 5 Chemotherapy Surgery Brigham and Women’s Hospital United States 8/2009
13.0 months Malignant Pleural Mesothelioma 4 Alternative Chemotherapy University of Turin Italy 4/2003
13.0 months Mesothelioma 5 Chemotherapy Surgery Brigham and Women’s Hospital United States 4/2006
12.7 months Malignant Pleural Mesothelioma 4 Chemotherapy Istituto Clinico Humanitas Italy 3/2006
12.7 months MPM 4 Chemotherapy Immunotherapy C. Forlanini Hospital Italy 1/2005
12.4 months Malignant pleural mesothelioma Surgery Medical University of Vienna Austria 4/2008
12.1 months Malignant Pleural Mesothelioma 5 Alternative Chemotherapy University of Chicago, Cancer Research Center United States 7/2003
12.0 months Malignant Pleural Mesothelioma 3 Radiation Surgery The University of Texas M. D. Anderson Cancer Center United States 3/2003
11.2 months MPM 5 Chemotherapy Emory University School of Medicine United States 5/2005
11.2 months Malignant pleural mesothelioma 4 Chemotherapy Sir Charles Gairdner Hospital Australia 8/2002
10.6 months Malignant Pleural Mesothelioma 4 Chemotherapy St Bartholomew’s Hospital United Kingdom 12/2000
10.5 months Malignant Mesothelioma 3 Biologic therapy < Chemotherapy The Royal Marsden Hospital United Kingdom 2/2002
10.3 months Malignant peritoneal mesothelioma 5 Chemotherapy Cardarelli Hospital Italy 5/2009
10.1 months Malignant pleural mesothelioma 4 Chemotherapy Institut Gustave Roussy France 1/2003
10.1 months Malignant pleural mesothelioma 4 Chemotherapy Dana Farber Cancer Institute United States 3/2008
10.0 months Malignant Mesothelioma 4 Chemotherapy National University Hospital, Rigshospitalet Denmark 4/1999
10.0 months Malignant pleural mesothelioma 4 Radiation Surgery Memorial Sloan-Kettering Cancer Center United States 10/2001
10.0 months Malignant Pleural Mesothelioma 5 Biologic therapy Surgery The Netherlands Cancer Institute Netherlands 10/2001
9.7 months Advanced malignant pleural mesothelioma 4 Chemotherapy Medical University of Gdansk Poland 4/2008
9.6 months Malignant Mesothelioma 5 Chemotherapy University of Chicago Medical Center United States 11/1999
9.6 months Malignant pleural mesothelioma 4 Chemotherapy Charing Cross Hospital United Kingdom 5/2008
9.5 months Malignant pleural mesothelioma 5 Chemotherapy Leeds General Infirmary United Kingdom 5/2008
9.4 months Malignant Pleural Mesothelioma 4 Chemotherapy University Hospital Rotterdam Netherlands 2/2002
9.3 months MPM 5 Chemotherapy University of Chicago United States 6/2005
9.3 months Malignant Pleural Mesothelioma 4 Chemotherapy Immunotherapy Istituto Clinico Humanitas Italy 8/2001
9.3 months Malignant Pleural Mesothelioma 4 Alternative Chemotherapy University of Chicago, Cancer Research Center United States 7/2003
9.0 months Malignant Pleural Mesothelioma 2 Immunotherapy St. Bartholomew’s Hospital United Kingdom 1/2001
8.8 months MPM 4 Chemotherapy St. Bartholomew’s Hospital United Kingdom 2/2005
8.8 months Malignant Pleural Mesothelioma 4 Chemotherapy University Hospital Vrije Universiteit Netherlands 11/1997
8.7 months Malignant Pleural Mesothelioma 1 Radiation Sir Charles Gairdner Hospital Australia 7/2004
8.5 months Malignant Pleural Mesothelioma 4 Chemotherapy The University of Texas M.D. Anderson Cancer Center United States 8/2000
8.2 months Malignant Pleural Mesothelioma 4 Chemotherapy Erasmus Medical Center Netherlands 4/2002
8.0 months Malignant Pleural Mesothelioma 4 Chemotherapy University of Turin Italy 4/2003
7.6 months MPM 3 Biologic therapy Netherlands Cancer Institute Netherlands 5/2005
7.0 months Malignant pleural mesothelioma 3 Chemotherapy The Netherlands Cancer Institute Netherlands 2/2003
7.0 months Malignant Mesothelioma 5 Chemotherapy Columbia University United States 7/2003
6.8 months Advanced mesothelioma 5 Chemotherapy Washington University School of Medicine United States 3/2005
6.6 months Malignant Mesothelioma 4 Chemotherapy University of Chicago Medical Center United States 11/1999
6.0 months Unresectable Malignant Mesothelioma 4 Chemotherapy Alfacell Corp. United States 1/2002
5.8 months Malignant pleural mesothelioma 4 Biologic therapy Dana-Farber Cancer Institute United States 6/2008
4.9 months Malignant Mesothelioma 5 Chemotherapy Ohio State University Comprehensive Cancer Center United States 5/2004
4.8 months Malignant Mesothelioma 5 Chemotherapy Scripps Clinic United States 11/2001
4.7 months Malignant Mesothelioma 5 Chemotherapy University of Chicago Medical Center United States 2/2001
3.2 months MPM 3 Chemotherapy San Matteo University Hospital Italy 6/2005
N/R Mesothelioma 3 Alternative University of Texas, M. D. Anderson Cancer Center United States 3/2001
N/R MPM 4 Biologic therapy Erasmus Medical Center Netherlands 2/2005
More Mesothelioma 4 Immunotherapy Memorial Hermann Hospital United States 12/2002
More Mesothelioma 4 Biologic therapy Massachusetts General Hospital United States 2/2001
More Malignant Pleural Mesothelioma 4 Chemotherapy IST Istituto Nazionale per la Ricerca sul Cancro Italy 11/2001
More Mesothelioma 4 Chemotherapy University of Minnesota Medical School United States 1/2002